View for an educational webinar presented by Robyn Bulham BSN, RN, OCN and Kelli Gingerich MSN, RN, AGACNP-BC from Bayer! This webinar aims to education patients and caregivers about Xofigo and the role it plays in treating prostate cancer.
-
Home
-
Digital Education Events
- The Role of Xofigo (Radium 223 dichloride) in Treating mCRPC
Prostate cancer is a disease that is most successfully treated when it is detected early on. As the research community explores various methods to detecting the disease, PCEC continues to encourage men to play an active role in their health by looking to those trusted sources of prostate cancer testing – the PSA and DRE.